News
CMM Among First to Offer New FDA-Approved Test to Aid in Treatment of Prostate Cancer
28 February 08
Center for Molecular Medicine Among First Labs in Nation to Offer Groundbreaking Test to Aid in Treatment of Colorectal Cancer
14 December 07
Center for Molecular Medicine Offers Xceed ZiplexTM
30 November 07
CMM Only Regional Provider of Test Suggested in FDA Alert on Prescribing Codeine to Nursing Mothers
22 August 07
CMM First Midwest-Based Lab Offering Roche Test to Help Predict Drug Performance & Improve Safety
14 June 07
Van Andel Institute and Spectrum Health Form Joint Venture To Create Center for Molecular Medicine
13 March 07
Check this area often for updates on the Center for Molecular Medicine, as well as links to related resources
Diagnostic Molecular Pathology editorial March 1, 2008
The CMM offers physicians and their patients FDA-approved microarray based tests to examine genotypes and circulating tumor cell patterns. Our menu of services is constantly growing.
The CLIA-licensed, CAP accredited,
GLP-like environment CMM offers the IVD,
biotech and pharma communities a full array of cost-effective genomic,
proteomic and bioinformatic services. Contact us about validation,
testing and data analysis.
© Copyright 2008 Center for Molecular Medicine